Concomitant Medication Effects on Immune Checkpoint Inhibitor Efficacy and Toxicity

There are multiple approved indications for immune checkpoint inhibitors (ICI) in patients with advanced solid tumors. Polypharmacy, defined as the use of ≥ 5 medications, is common among cancer patients. The impact of these non-oncologic medications on ICI efficacy or the development of side effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Sieber, Brendan, Strauss, Julius, Li, Zihai, Gatti-Mays, Margaret E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9196183/
https://www.ncbi.nlm.nih.gov/pubmed/35712518
http://dx.doi.org/10.3389/fonc.2022.836934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9196183/
https://www.ncbi.nlm.nih.gov/pubmed/35712518
http://dx.doi.org/10.3389/fonc.2022.836934

Ejemplares similares